Polymers for drug delivery systems

Annual Review of Chemical and Biomolecular Engineering

Volumn 1, Issue , 2010, Pages 149-173

  Liechty, William B ^a   Kryscio, David R ^a   Slaughter, Brandon V ^a   Peppas, Nicholas A ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

controlled release; intracellular delivery; polymer therapeutics; recognitive polymers; responsive polymers; stimuli responsive

Indexed keywords

CONTROLLED RELEASE; INTRACELLULAR DELIVERY; POLYMER THERAPEUTICS; RECOGNITIVE POLYMERS; RESPONSIVE POLYMER; STIMULI-RESPONSIVE;

CONTROLLED DRUG DELIVERY; DRUG DOSAGE; FUNCTIONAL POLYMERS; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; RATIONAL FUNCTIONS;

POLYMERS;

DRUG; POLYMER; PROTEIN;

ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; HUMAN; REVIEW;

ANIMALS; DELAYED-ACTION PREPARATIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYMERS; PROTEINS;

EID: 78651379819     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-073009-100847     Document Type: Article

References (149)

1. Heller A. 2005. Integrated medical feedback systems for drug delivery. AIChE J. 51(4):1054-66 (Pubitemid 40554068)
2. Langer R, Peppas NA. 2003. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 49(12):2990-3006 (Pubitemid 38009884)
3. Rowe RC, Sheskey PJ, Owen SC. 2005. Handbook of Pharmaceutical Excipients. Grayslake, IL: Pharmaceutical Press/ Washington, D.C.: American Pharmacists Association. 850 pp. 5th ed.
4. Verma RK, Mishra B, Garg S. 2000. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26(7):695-708 (Pubitemid 30397323)
5. Langer RS, PeppasNA. 1981. Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2(4):201-14 (Pubitemid 12195193)
6. Peppas NA. 2008. Drug delivery using smart polymers: recent advances. In Smart Polymers: Applications in Biotechnology and Biomedicine, ed. IM Galaev, B Mattiasson. Boca Raton, FL: CRC Press. 2nd ed.
7. Crank J. 1975. The Mathematics of Diffusion. New York: Oxford Univ. Press. 414 pp. 2nd ed.
8. Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52(12):114-49
9. Koizumi T, Panomsuk SP. 1995. Release of medicaments from spherical matrices containing drug in suspension: theoretical aspects. Int. J. Pharm. 116(1):45-49
10. Cohen DS, Erneux T. 1998. Controlled drug release asymptotics. Siam J. Appl. Math. 58(4):1193-204 (Pubitemid 128689429)
11. Colombo P, Bettini R, Santi P, Peppas NA. 2000. Swellable matrices for controlled drug delivery: gellayer behaviour, mechanisms and optimal performance. Pharm. Sci. Technol. Today 3(6):198-204 (Pubitemid 30364933)
12. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15(1):25-35 (Pubitemid 13092121)
13. Ritger PL, Peppas NA. 1987. A simple equation for description of solute release. I. Fickian and nonfickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Control. Release 5(1):23-36 (Pubitemid 17106643)
14. Ritger PL, Peppas NA. 1987. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J. Control. Release 5(1):37-42 (Pubitemid 17106644)
15. Kim H, Fassihi R. 1997. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics. J. Pharm. Sci. 86(3):323-28 (Pubitemid 27113766)
16. LindnerWD, Lippold BC. 1995. Drug-release from hydrocolloid embeddings with high or low susceptibility to hydrodynamic stress. Pharm. Res. 12(11):1781-85 (Pubitemid 26004702)
17. Peppas NA, Sahlin JJ. 1989. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int. J. Pharm. 57(2):169-72 (Pubitemid 20011841)
18. Arifin DY, Lee LY, Wang CH. 2006. Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems. Adv. Drug Deliv. Rev. 58(12-13):1274-325
19. Masaro L, Zhu XX. 1999. Physical models of diffusion for polymer solutions, gels and solids. Prog. Polym. Sci. 24(5):731-75 (Pubitemid 30497914)
20. Tamada JA, Langer R. 1993. Erosion kinetics of hydrolytically degradable polymers. Proc. Natl. Acad. Sci. USA 90(2):552-56 (Pubitemid 23028901)
21. Nair LS, Laurencin CT. 2007. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32(8-9):762-98 (Pubitemid 47198287)
22. Park K, ShalabyW, PaarkH. 1993. Biodegradable Hydrogels for Drug Delivery. Lancaster, PA: Technomic
23. Mayersohn M. 2009. Principles of drug absorption. In Modern Pharmaceutics, ed. AT Florence, J Siepmann, pp. 23-80. New York: Informa Healthcare. 5th ed.
24. Takakura Y, Hashida M, Sezaki H. 1992. Lymphatic transport after paraentersal drug administration. In Lymphatic Transport of Drugs, ed.WCharman, V Stella, pp. 255-77. Boca Raton, FL: CRC Press
25. Gil ES, Hudson SA. 2004. Stimuli-reponsive polymers and their bioconjugates. Prog. Polym. Sci. 29(12):1173-222
26. Schmaljohann D. 2006. Thermo-and pH-responsive polymers in drug delivery. Adv. Drug Deliv. Rev. 58(15):1655-70 (Pubitemid 44830149)
27. Schild HG. 1992. Poly (N-isopropylacrylamide): experiment, theory and application. Prog. Polym. Sci. 17(2):163-249
28. Khare AR, Peppas NA. 1995. Swelling/deswelling of anionic copolymer gels. Biomaterials 16(7):559-67
29. Malmsten M, Lindman B. 1992. Self-assembly in aqueous block copolymer solutions. Macromolecules 25(20):5440-45 (Pubitemid 23572195)
30. Topp MDC, Jijkstra PJ, Talsma H, Feijen J. 1997. Thermosensitive micelle-forming block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide). Macromolecules 30(26):8518-20 (Pubitemid 127569672)
31. QiuY, ParkK. 2001. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 53(3):321-39 (Pubitemid 34024913)
32. Ruel-Garíepy E, Leroux J-C. 2004. In situ-forming hydrogels-review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58(2):409-26
33. AlarconCDH,Pennadam S,AlexanderC. 2005. Stimuli responsive polymers for biomedical applications. Chem. Soc. Rev. 34(3):276-85 (Pubitemid 40444408)
34. Ganta S, Devalapally H, Shahiwala A, Amiji M. 2008. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release 126(3):187-204
35. Hoare TR, Kohane DS. 2008. Hydrogels in drug delivery: progress and challenges. Polymer 49(8):1993-2007
36. Kost J, Langer R. 2001. Responsive polymeric delivery systems. Adv. Drug Deliv. Rev. 46(1-3):125-48 (Pubitemid 33653418)
37. Peppas NA, Bures P, Leobandung W, Ichikawa H. 2000. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50(1):27-46 (Pubitemid 30326687)
38. Lowman AM, Morishita M, Kajita M, Nagai T, Peppas NA. 1999. Oral delivery of insulin using pHresponsive complexation gels. J. Pharm. Sci. 88(9):933-37 (Pubitemid 29438959)
39. Torres-Lugo M, PeppasNA. 1999. Molecular design and in vitro studies of novel pH-sensitive hydrogels for the oral delivery of calcitonin. Macromolecules 32(20):6646-51
40. Kamei N, Morishita M, Chiba H, Kavimandan NJ, Peppas NA, Takayama K. 2009. Complexation hydrogels for intestinal delivery of interferon âand calcitonin. J. Control. Release 134(2):98-102
41. Alexandridis P, Holzwarth JF, Hatton TA. 1994. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: thermodynamics of copolymer association. Macromolecules 27(9):2414-25
42. Boussif O, Lezoualc'h F, Zanta MA, Hergny MD, Scherman D, et al. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethyleneimine. Proc. Natl. Acad. Sci. USA 92(16):7297-301
43. MokH, Park TG. 2009. Functional polymers for targeted delivery of nucleic acid drugs. Macromol. Biosci. 9(8):731-43
44. Gosselin MA,Guo WJ, Lee RJ. 2001. Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug. Chem. 12(6):989-94 (Pubitemid 33136869)
45. Godbey WT, Wu KK, Mikos AG. 1999. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. 45(3):268-75 (Pubitemid 29165943)
46. Tanaka T. 1978. Collapse of gels and critical endpoint. Phys. Rev. Lett. 40(12):820-23
47. Duscaronek K, Patterson D. 1968. Transition in swollen polymer networks induced by intramolecular condensation. J. Polym. Sci. Part A 6(7):1209-16
48. HeskinsM, Guillet JE. 1968. Solution properties of poly(N- isopropylacrylamide). J. Macromol. Sci. Pure Appl. Chem. 2(8):1441-55
49. BaeYH, OkanoT,Kim SW. 1990. Temperature-dependence of swelling of cross-linked poly(N,N-alkyl substituted acrylamides) in water. J. Polym. Sci. Part B 28(6):923-36 (Pubitemid 20684891)
50. Shibayama M, Tanaka T. 1993. Volume phase-transition and related phenomena of polymer gels. Adv. Polym. Sci. 109:1-62
51. Kopecek J. 2003. Smart and genetically engineered biomaterials and drug delivery systems. Eur. J. Pharm. Sci. 20(1):1-16 (Pubitemid 37103227)
52. Inomata H, Goto S, Saito S. 1990. Phase-transition of N-substituted acrylamide gels. Macromolecules 23(22):4887-88
53. Katono H, Maruyama A, Sanui K, Ogata N, Okano T, Sakurai Y. 1991. Thermoresponsive swelling and drug release switching of interpenetrating polymer networks composed of poly(acrylamide-co-butyl methacrylate) and poly(acrylic-acid). J. Control. Release 16(1-2):215-27
54. Klouda L, Mikos AG. 2008. Thermoresponsive hydrogels in biomedical applications. Eur. J. Pharm. Biopharm. 68(1):34-45 (Pubitemid 350181413)
55. Bhattarai N, Ramay HR, Gunn J, Matsen FA, Zhang M. 2005. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J. Control. Release 103(3):609-24 (Pubitemid 40471019)
56. De P, Gondi SR, Sumerlin BS. 2008. Folate-conjugated thermoresponsive block copolymers: highly efficient conjugation and solution self-assembly. Biomacromolecules 9(3):1064-70 (Pubitemid 351560503)
57. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol. Rev. 77(3):759-803 (Pubitemid 27328740)
58. Mellman I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:575-625 (Pubitemid 26422725)
59. Vaupel P, Kallinowski F, Okunieff P. 1989. Blood-flow, oxygen and nutrient supply, and metabolic microenvironment of human-tumors: a review. Cancer Res. 49(23):6449-65 (Pubitemid 20008770)
60. Fisher OZ, Peppas NA. 2009. Polybasic nanomatrices prepared by UV-initiated photopolymerization. Macromolecules 42(9):3391-98
61. Fisher O, Kim T, Dietz SR, Peppas NA. 2009. Enhanced core hydrophobicity, functionalization and cell penetration of polybasic nanomatrices. Pharm. Res. 26(1):51-60
62. HuY, Litwin T, Nagaraja AR,Kwong B, Katz J, et al. 2007. Cytosolic delivery ofmembrane-impermeable molecules in dendritic cells using pH-responsive core-shell nanoparticles. Nano Lett. 7(10):3056-64 (Pubitemid 350132930)
63. Hu Y, Atukorale PU, Lu JJ, Moon JJ, Um SH, et al. 2009. Cytosolic delivery mediated via electrostatic surface binding of protein, virus, or siRNA cargos to pH-responsive core-shell gel particles. Biomacromolecules 10(4):756-65
64. Owens DE, Peppas NA. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307(1):93-102 (Pubitemid 41773257)
65. Lee ES, Na K, Bae YH. 2005. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J. Control. Release 103(2):405-18 (Pubitemid 40342538)
66. Lee ES, Gao Z, Kim D, Park K, Kwan IC, Bae YH. 2008. Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance. J. Control. Release 129(3):228-36
67. LeeES, Na K, Bae YH. 2005. Super pH-sensitive multifunctional polymeric micelle. Nano Lett. 5(2):325-29 (Pubitemid 40308294)
68. Byrne JD, Betancourt T, Brannon-Peppas L. 2008. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv. Drug Deliv. Rev. 60(15):1615-26
69. Guelen L, Paterson H, Gäken J, Meyers M, Farzaneh F, Tavassoli M. 2003. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells. Oncogene 23(5):1153-65
70. Sethuraman VA, Bae YH. 2007. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. J. Control. Release 118(2):216-24 (Pubitemid 46350711)
71. Mathiowitz E, Jacob JS, Jong YS, Carino GP, Chickering DE, et al. 1997. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386(6623):410-14 (Pubitemid 27154483)
72. Leong KW, Brott BC, Langer R. 1985. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J. Biomed. Mater. Res. 19(8):941-55 (Pubitemid 16257502)
73. Cohen S, YoshiokaT, Lucarelli M, Hwang LH, LangerR. 1991. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm. Res. 8(6):713-20
74. Shenoy D, Little S, Langer R, Amiji M. 2005. Poly(ethylene oxide)-modified poly(â-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol. Pharm. 2(5):357-66 (Pubitemid 41503676)
75. Shenoy D, Little S, Langer R, Amiji M. 2005. Poly(ethylene oxide)-modified poly(â-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. Part 2. In vivo distribution and tumor localization studies. Pharm. Res. 22(12):2107-14 (Pubitemid 41821590)
76. Cerritelli S, Velluto D, Hubbell JA. 2007. PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery. Biomacromolecules 8(6):1966-72 (Pubitemid 47009977)
77. Oh JK, Siegart DJ, Lee H, Sherwood G, Peteanu L, et al. 2007. Biodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugation. J. Am. Chem. Soc. 129(18):5939-45 (Pubitemid 46748500)
78. Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, et al. 2009. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 10(1):119-27
79. Dufresne MH, ElsabahyM, Leroux JC. 2008. Characterization of polyion complex micelles designed to address the challenges of oligonucleotide delivery. Pharm. Res. 25(9):2083-93
80. Davis ME, Chen Z, Shin DM. 2008. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9):771-82
81. Duncan R. 2003. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2(5):347-60 (Pubitemid 37361705)
82. Duncan R. 2006. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 6(9):688-701 (Pubitemid 44286001)
83. Roberts MJ, Bentley MD, Harris JM. 2002. Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54(4):459-76 (Pubitemid 34615543)
84. Vicent MJ, Dieudonńe L, Carbajo RJ, Pineda-Lucena A. 2008. Polymer conjugates as therapeutics: future trends, challenges and opportunities. Expert Opin. Drug Deliv. 5(5):593-614 (Pubitemid 351888105)
85. Matsumura Y, Maeda H. 1986. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumortropic accumulation of proteins and the antitumor agent Smancs. Cancer Res. 46(12):6387-92 (Pubitemid 17221789)
86. Minchinton AI, Tannock IF. 2006. Drug penetration in solid tumours. Nat. Rev. Cancer 6(8):583-92 (Pubitemid 44140857)
87. Pasut G, Veronese FM. 2007. Polymer-drug conjugation, recent achievements and general strategies. Prog. Polym. Sci. 32:933-61 (Pubitemid 47198290)
88. Heredia KL, Maynard HD. 2007. Synthesis of protein-polymer conjugates. Org. Biomol. Chem. 5(1):45-53 (Pubitemid 44927098)
89. Bontempo D, Maynard HD. 2005. Streptavidin as a macroinitiator for polymerization: in situ proteinpolymer conjugate formation. J. Am. Chem. Soc. 127(18):6508-9 (Pubitemid 40664138)
90. Boyer C, Bulmus V, Liu J, Davis TP, Stenzel MH, Barner-Kowollik C. 2007. Well-defined proteinpolymer conjugates via in situ RAFT polymerization. J. Am. Chem. Soc. 129(22):7145-54 (Pubitemid 46903280)
91. Brocchini S, Duncan R. 1999. Pendant drugs, release from polymers. In Encyclopedia of Controlled Drug Delivery, ed. E Mathiowitz, pp. 786-816. New York: Wiley
92. Harris JM, Chess RB. 2003. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2(3):214-21 (Pubitemid 37361666)
93. Ringsdorf H. 1975. Structure and properties of pharmacologically active polymers. J. Polymer Sci. Part C 51(1):135-53
94. Duncan R, Kopecek J. 1984. Soluble synthetic-polymers as potential drug carriers. Adv. Polym. Sci. 57:51-101
95. Duncan R, Lloyd JB, Kopecek J. 1980. Degradation of side-chains of N-(2-hydroxypropyl) methacrylamide copolymers by lysosomal enzymes. Biochem. Biophys. Res. Commun. 94(1):284-90
96. Khandare J, Minko T. 2006. Polymer-drug conjugates: progress in polymeric prodrugs. Prog. Polym. Sci. 31(4):359-97
97. Kopeček J,Kopečkov́a P,Minko T, Lu Z-R. 2000.HPMAcopolymer-anticancer drug conjugates: design, activity, and mechanism of action. Eur. J. Pharm. Biopharm. 50(1):61-81 (Pubitemid 30326689)
98. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, et al. 2004. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat. Med. 10(3):255-61 (Pubitemid 38667615)
99. Chesler L, Goldenberg DD, Seales IT, Satchi-Fainaro RS, Grimmer M, et al. 2007. Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma. Cancer Res. 67:9435-42 (Pubitemid 47541995)
100. Satchi-Fainaro R,Mamluk R,Wang L, Short SM,Nagy JA, et al. 2005. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7(3):251-61 (Pubitemid 40568684)
101. Khandare JJ, Jayant S, Singh A, Chandna P, Wang Y, et al. 2006. Dendrimer versus linear conjugate: influence of polymeric architecture on the delivery and anticancer effect of paclitaxel. Bioconjug. Chem. 17(6):1464-72 (Pubitemid 44851491)
102. Abuchowski A, McCoy JR, Palczuk NC, van Es T, Davis FF. 1977. Effect of covalent attachment of polyethylene-glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. 252(11):3582-86 (Pubitemid 8116088)
103. Abuchowski A, van Es T, PalczukNC, Davis FF. 1977. Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol. J. Biol. Chem. 252(11):3578-81 (Pubitemid 8116087)
104. Veronese FM, Mero A. 2008. The impact of PEGylation on biological therapies. Biodrugs 22(5):315-29
105. Duncan R, Gilbert HRP, Carbajo RJ, Vicent MJ. Polymer masked-unmasked protein therapy. 1. Bioresponsive dextrin-trypsin and-melanocyte stimulating hormone conjugates designed for á-amylase activation. Biomacromolecules 9(4):1146-54
106. NishiyamaN, Kataoka K. 2006. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112(3):630-48 (Pubitemid 44592613)
107. Wiradharma N, Zhang Y, Venkataraman S,Hedrick JL, Yang YY. 2009. Self-assembled polymer nanostructures for delivery of anticancer therapeutics. Nano Today 4(4):302-17
108. Bae Y, Fukushima S, Harada A, Kataoka K. 2003. Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: polymeric micelles that are responsive to intracellular pH change. Angew. Chem. Int. Ed. 42(38):4640-43 (Pubitemid 37271305)
109. Bae Y,Nishiyama N, Fukushima S,KoyamaH, YasuhiroM,Kataoka K. 2005. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug. Chem. 16(1):122-30 (Pubitemid 40129685)
110. Han M, Bae Y, Nishiyama N, Miyata K, Oba M, Kataoka K. 2007. Transfection study using multicellular tumor spheroids for screening non-viral polymeric gene vectors with low cytotoxicity and high transfection efficiencies. J. Control. Release 121(1-2):38-48 (Pubitemid 47126063)
111. Kang SI, Na K, Bae YH. 2003. Physicochemical characteristics and doxorubicin-release behaviors of pH/temperature-sensitive polymeric nanoparticles. Colloids Surf. A 231(1-3):103-12 (Pubitemid 38096279)
112. Soppimath KS, Liu L-H, Seow WY, Liu S-Q, Powell R, et al. 2007. Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery. Adv. Funct. Mater. 17(3):355-62
113. BaeY, Jang W-D,Nishiyama N, Fukushima S,Kataoka K. 2005. Multifunctional polymeric micelleswith folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. Mol. Biosyst. 1(3):242-50 (Pubitemid 41442434)
114. Bae Y, Nishiyama N, Kataoka K. 2007. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug. Chem. 18(4):1131-39 (Pubitemid 47122634)
115. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, et al. 1992. Distribution of the folate receptor GP38 in normal and malignant-cell lines and tissues. Cancer Res. 52(12):3396-401
116. Greco F, Vicent MJ, Gee S, Jones AT, Gee J, et al. 2007. Investigating the mechanism of enhanced cytotoxicity of HPMA copolymer-Dox-AGM in breast cancer cells. J. Control. Release 117(1):28-39 (Pubitemid 46164864)
117. Greco F, Vicent MJ, Penning NA, Nicholson RI, Duncan R. 2005. HPMA copolymeraminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines. J. Drug Target. 13(8-9):459-70 (Pubitemid 43347843)
118. Lammers T, Subr V, Ulbrich K, Peschke P,Huber PE, et al. 2009. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials 30(20):3466-75
119. Hilt JZ, Byrne ME. 2004. Configurational biomimesis in drug delivery: molecular imprinting of biologically significant molecules. Adv. Drug Deliv. Rev. 56(11):1599-620 (Pubitemid 39177691)
120. Kryscio DR, Peppas NA. 2009. Mimicking biological delivery through feedback-controlled drug release systems based on molecular imprinting. AIChE J. 55(6):1311-24
121. Alvarez-Lorenzo C, Concheiro A. 2004. Molecularly imprinted polymers for drug delivery. J. Chromatogr. B 804(1):231-45 (Pubitemid 38469889)
122. Ali M, Byrne ME. 2009. Controlled release of high molecular weight hyaluronic acid from molecularly imprinted hydrogel contact lenses. Pharm. Res. 26(3):714-26
123. Ali M, Horikawa S, Venkatesh S, Saha J, Hong JW, Byrne ME. 2007. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow. J. Control. Release 124(3):154-62 (Pubitemid 350110488)
124. Alvarez-Lorenzo C, Hiratani H, Ǵomez-Amoza JL,Mart́inez- Pacheco R, Souto C, Conchiero A. 2002. Soft contact lenses capable of sustained delivery of timolol. J. Pharm. Sci. 91(10):2182-92
125. Hiratani H, Alvarez-Lorenzo C. 2002. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid. J. Control. Release 83(2):223-30 (Pubitemid 35279467)
126. Hiratani H, Alvarez-Lorenzo C. 2004. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems. Biomaterials 25(6):1105-13 (Pubitemid 37393300)
127. Hiratani H, Fujiwara A, Tamiya Y, Mizutani Y, Alvarez-Lorenzo C. 2005. Ocular release of timolol from molecularly imprinted soft contact lenses. Biomaterials 26(11):1293-98 (Pubitemid 39314503)
128. Venkatesh S, Sizemore SP, Byrne ME. 2007. Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics. Biomaterials 28(4):717-24 (Pubitemid 44754878)
129. Venkatesh S, Saha J, Pass S, Byrne ME. 2008. Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery. Eur. J. Pharm. Biopharm. 69(3):852-60
130. PackDW,Hoffman AS, Pun S, Stayton PS. 2005. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4(7):581-93 (Pubitemid 40975711)
131. Whitehead KA, Langer R, Anderson DG. 2009. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8(2):129-38
132. Verma A, Uzun O, Hu Y, Hu Y, Han H-S, et al. 2008. Surface-structure- regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat. Mater. 7(7):588-95
133. Yessine M-A, Leroux J-C. 2004. Membrane-destabilizing polyanions: interaction with lipid bilayers and endosomal escape of biomacromolecules. Adv. Drug Deliv. Rev. 56:999-1021 (Pubitemid 38520206)
134. Kurisawa M, Yokoyama M, Okano T. 2000. Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J. Control. Release 68(1):1-8 (Pubitemid 30407057)
135. Lackey CA, Press OW, Hoffman AS, Stayton PS. 2002. A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex. Bioconjug. Chem. 13(5):996-1001
136. Murthy N, Robichaud JR, Tirrell DA, Stayton PS, Hoffman AS. 1999. The design and synthesis of polymers for eukaryotic membrane disruption. J. Control. Release 61(1-2):137-43 (Pubitemid 29406087)
137. Murthy N, Chang I, Stayton P, Hoffman A. 2001. pH-sensitive hemolysis by random copolymers of alkyl acrylates and acrylic acid. Macromol. Symp. 172:49-55
138. Lee ES, Kim D, Youn YS, Oh KT, Bae YH. 2008. A virus-mimetic nanogel vehicle. Angew. Chem. Int. Ed. 47(13):2418-21
139. Convertine AJ, Benoit DSW, Duvall CL, Hoffman AS, Stayton PS. 2009. Development of a novel endosomolytic diblock copolymer for siRNA delivery. J. Control. Release 133(3):221-29
140. Chen RJ, Khormaee S, Eccleston ME, Slater NKH. 2009. Effect of L-leucine graft content on aqueous solution behavior and membrane-lytic activity of a pH-responsive pseudopeptide. Biomacromolecules 10(9):2601-8
141. Chen R, Khormaee S, Eccleston ME, Slater NKH. 2009. The role of hydrophobic amino acid grafts in the enhancement of membrane-disruptive activity of pH-responsive pseudo-peptides. Biomaterials 30(10):1954-61
142. Chen RJ, Yue Z, Eccleston ME, Slater NKH. 2008. Aqueous solution behaviour and membrane disruptive activity of pH-responsive PEGylated pseudo-peptides and their intracellular distribution. Biomaterials 29(32):4333-40
143. Chen RJ, Yue Z, Eccleston ME, Williams S, Slater NKH. 2005. Modulation of cellmembrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains. J. Control. Release 108(1):63-72 (Pubitemid 41476675)
144. LiechtyWB, Chen R, Farzaneh F, Tavassoli M, Slater NKH. 2009. Synthetic pH-responsive polymers for protein transduction. Adv. Mater. 21(38-39)3910-14
145. Owens DE, Eby JK, Jian Y, Peppas NA. 2007. Temperature-responsive polymer-gold nanocomposites as intelligent therapeutic systems. J. Biomed. Mater. Res. Part A 83A(3):692-95 (Pubitemid 350086295)
146. Sershen SR, Westcott SL,West JL, Halas NJ. 2001. An opto-mechanical nanoshell-polymer composite. Appl. Phys. B 73(4):379-81 (Pubitemid 33091183)
147. Satarkar NS, Hilt JZ. 2008. Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J. Control. Release 130(3):246-51
148. Arias JL, Gallardo V, Ruiz MA, Delgado AV. 2008. Magnetite/ poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-fluorouracil delivery systems for active targeting. Eur. J. Pharm. Biopharm. 69(1):54-63
149. Mornet S, Vasseur S, Grasset F, Duguet E. 2004. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14(14):2161-75